AstraZeneca PLC (AZN) - Total Liabilities

Latest as of March 2026: GBX66.63 Billion GBX ≈ $8.11 Million USD

Based on the latest financial reports, AstraZeneca PLC (AZN) has total liabilities worth GBX66.63 Billion GBX (≈ $8.11 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

AstraZeneca PLC - Total Liabilities Trend (1990–2025)

This chart illustrates how AstraZeneca PLC's total liabilities have evolved over time, based on quarterly financial data. See AZN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

AstraZeneca PLC Competitors by Total Liabilities

The table below lists competitors of AstraZeneca PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Olin Corporation NYSE:OLN	USA	$5.40 Billion
Sunway Construction Group Bhd KLSE:5263	Malaysia	RM3.68 Billion
Bloomage Biotechnology Corp Ltd SHG:688363	China	CN¥1.59 Billion
Chicony Electronics Co Ltd TW:2385	Taiwan	NT$48.71 Billion
Fuchs Petrolub SE XETRA:FPE	Germany	€827.00 Million
IGB Real Estate Investment Trust KLSE:5227	Malaysia	RM1.47 Billion
Sime Darby Property Bhd KLSE:5288	Malaysia	RM7.64 Billion
Malaysian Pacific Industries KLSE:3867	Malaysia	RM956.47 Million

Liability Composition Analysis (1990–2025)

This chart breaks down AstraZeneca PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AstraZeneca PLC (AZN) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AstraZeneca PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AstraZeneca PLC (1990–2025)

The table below shows the annual total liabilities of AstraZeneca PLC from 1990 to 2025.

Year	Total Liabilities	Change
2025-12-31	GBX65.36 Billion ≈ $7.95 Million	+3.47%
2024-12-31	GBX63.16 Billion ≈ $7.69 Million	+1.95%
2023-12-31	GBX61.95 Billion ≈ $7.54 Million	+4.25%
2022-12-31	GBX59.42 Billion ≈ $7.23 Million	-10.07%
2021-12-31	GBX66.08 Billion ≈ $8.04 Million	+29.33%
2020-12-31	GBX51.09 Billion ≈ $6.22 Million	+9.21%
2019-12-31	GBX46.78 Billion ≈ $5.69 Million	+0.37%
2018-12-31	GBX46.61 Billion ≈ $5.67 Million	-0.22%
2017-12-31	GBX46.71 Billion ≈ $5.68 Million	+1.86%
2016-12-31	GBX45.86 Billion ≈ $5.58 Million	+10.19%
2015-12-31	GBX41.62 Billion ≈ $5.06 Million	+6.84%
2014-12-31	GBX38.95 Billion ≈ $4.74 Million	+19.31%
2013-12-31	GBX32.65 Billion ≈ $3.97 Million	+10.36%
2012-12-31	GBX29.58 Billion ≈ $3.60 Million	+0.76%
2011-12-31	GBX29.36 Billion ≈ $3.57 Million	-10.27%
2010-12-31	GBX32.72 Billion ≈ $3.98 Million	-4.05%
2009-12-31	GBX34.10 Billion ≈ $4.15 Million	+10.39%
2008-12-31	GBX30.89 Billion ≈ $3.76 Million	-6.51%
2007-12-31	GBX33.04 Billion ≈ $4.02 Million	+127.62%
2006-12-31	GBX14.52 Billion ≈ $1.77 Million	+30.20%
2005-12-31	GBX11.15 Billion ≈ $1.36 Million	-0.05%
2004-12-31	GBX11.15 Billion ≈ $1.36 Million	+8.13%
2003-12-31	GBX10.32 Billion ≈ $1.26 Million	-0.38%
2002-12-31	GBX10.36 Billion ≈ $1.26 Million	+16.78%
2001-12-31	GBX8.87 Billion ≈ $1.08 Million	-0.34%
2000-12-31	GBX8.90 Billion ≈ $1.08 Million	-6.04%
1999-12-31	GBX9.47 Billion ≈ $1.15 Million	+26.33%
1998-12-31	GBX7.50 Billion ≈ $912.05K	+60.91%
1997-12-31	GBX4.66 Billion ≈ $566.80K	-4.95%
1996-12-31	GBX4.90 Billion ≈ $596.33K	+1.40%
1995-12-31	GBX4.83 Billion ≈ $588.09K	+5.23%
1994-12-31	GBX4.59 Billion ≈ $558.87K	-9.94%
1993-12-31	GBX5.10 Billion ≈ $620.56K	-15.25%
1992-12-31	GBX6.02 Billion ≈ $732.24K	+10.52%
1991-12-31	GBX5.45 Billion ≈ $662.52K	+0.49%
1990-12-31	GBX5.42 Billion ≈ $659.26K	--

About AstraZeneca PLC

LSE:AZN UK Drug Manufacturers - General

Market Cap

$2.50 Billion

GBX20.52 Trillion GBX

Market Cap Rank

#5609 Global

#11 in UK

Share Price

GBX13234.00

Change (1 day)

+0.61%

52-Week Range

GBX10120.00 - GBX15542.00

All Time High

GBX15542.00